NCT05915364 MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY Status UNKNOWN Phase N/A
NCT05913271 Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure Status UNKNOWN Phase N/A
NCT05911724 Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin. Status COMPLETED Phase N/A
NCT05910866 LEft Bundle branchArea Pacing to Avoid Pacing-induced CARdiomyopathy Status RECRUITING Phase NA
NCT05908617 Impact of Video Discharge Instructions on Heart Failure Patient's Knowledge Status WITHDRAWN Phase NA
NCT05906745 Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure. Status COMPLETED Phase N/A
NCT05896904 Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction Status UNKNOWN Phase NA
NCT05892146 Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05890131 Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy Status COMPLETED Phase NA
NCT05885607 Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05881278 XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05880160 Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05873881 COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease Status RECRUITING Phase PHASE3